Return of the Coronavirus: 2019-nCoV

The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.

Saved in:
Bibliographic Details
Published inViruses Vol. 12; no. 2; p. 135
Main Authors Gralinski, Lisa E, Menachery, Vineet D
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 24.01.2020
MDPI AG
Subjects
2019-ncov
Animals
Betacoronavirus - genetics
Betacoronavirus - isolation & purification
China
Communicable Diseases, Emerging
coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - transmission
Coronavirus Infections - virology
COVID-19
Disease Outbreaks
Disease Reservoirs
Disease Susceptibility
emerging viruses
Genome, Viral
Humans
mers-cov
novel cov
Nucleocapsid Proteins - chemistry
Pneumonia, Viral - epidemiology
Pneumonia, Viral - transmission
Pneumonia, Viral - virology
SARS Virus - chemistry
SARS Virus - genetics
sars-cov
SARS-CoV-2
Severe Acute Respiratory Syndrome - epidemiology
Severe Acute Respiratory Syndrome - virology
Social Media
Spike Glycoprotein, Coronavirus - chemistry
Spike Glycoprotein, Coronavirus - metabolism
wuhan
wuhan pneumonia
Zoonoses
China
Wuhan pneumonia
novel CoV
emerging viruses
SARS-CoV
Wuhan
coronavirus
MERS-CoV
2019-nCoV
Online AccessGet full text

Cover

More Information
Summary:The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1999-4915
1999-4915
DOI:10.3390/v12020135